JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
NTES-S
09999
TRIP.COM-S
09961
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 41.30%-263.66M | ---- | 78.47%-449.2M | ---- | -1,107.93%-2.09B | ---- | 65.97%-172.7M | ---- | -669.71%-507.52M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 85.88%-149K | ---- | 48.76%-1.06M | ---- | 39.74%-2.06M | ---- | -7.08%-3.42M | ---- | 4.55%-3.19M |
Attributable subsidiary (profit) loss | ---- | 744.22%235.25M | ---- | -458.04%-36.52M | ---- | 117.71%10.2M | ---- | -157.89%-57.6M | ---- | 393.60%99.51M |
Impairment and provisions: | ---- | -111.01%-22.19M | ---- | -55.49%201.66M | ---- | -49.79%453.1M | ---- | 389.47%902.42M | ---- | 1,016.66%184.37M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -66.28%61.88M | ---- | 14,235.70%183.5M | ---- | --1.28M | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | -18.96%115.32M | ---- | -77.79%142.3M | ---- | 3,414.40%640.78M | ---- | --18.23M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 13,232.91%42.13M |
-Other impairments and provisions | ---- | -190.75%-22.19M | ---- | -80.79%24.46M | ---- | -51.10%127.31M | ---- | 109.96%260.36M | ---- | 706.99%124M |
Revaluation surplus: | ---- | -68.96%9.8M | ---- | -98.08%31.57M | ---- | 398.61%1.65B | ---- | -411.21%-551.16M | ---- | 544.35%177.1M |
-Fair value of investment properties (increase) | ---- | -68.96%9.8M | ---- | -93.43%31.57M | ---- | 17.70%480.55M | ---- | 974.97%408.29M | ---- | -20.52%-46.66M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | 221.45%1.17B | ---- | -528.77%-959.45M | ---- | 19,745.83%223.77M |
Asset sale loss (gain): | ---- | -604.31%-58.06M | ---- | 96.12%-8.24M | ---- | -61.89%-212.69M | ---- | -48.36%-131.39M | ---- | -81.67%-88.56M |
-Loss (gain) from sale of subsidiary company | ---- | -526.43%-59.32M | ---- | 95.33%-9.47M | ---- | -53.96%-202.91M | ---- | -48.79%-131.79M | ---- | ---88.57M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 2.77%1.26M | ---- | 112.52%1.23M | ---- | -2,505.16%-9.79M | ---- | 2,613.33%407K | ---- | 100.61%15K |
Depreciation and amortization: | ---- | -77.98%20.02M | ---- | -32.71%90.95M | ---- | 228.97%135.17M | ---- | -21.24%41.09M | ---- | 1.85%52.17M |
-Depreciation | ---- | -84.98%6.29M | ---- | -14.48%41.92M | ---- | 67.38%49.02M | ---- | -29.34%29.28M | ---- | -17.49%41.45M |
-Amortization of intangible assets | ---- | -99.75%45K | ---- | -58.80%18.17M | ---- | 47,832.61%44.1M | ---- | -80.67%92K | ---- | -51.72%476K |
Financial expense | ---- | -89.99%6.63M | ---- | 2.21%66.18M | ---- | 267.70%64.75M | ---- | -26.64%17.61M | ---- | -25.00%24.01M |
Unrealized exchange loss (gain) | ---- | -90.21%962K | ---- | 236.57%9.83M | ---- | 56.84%-7.2M | ---- | -227.87%-16.68M | ---- | 33.58%13.04M |
Special items | ---- | -117,042.86%-8.2M | ---- | 91.95%-7K | ---- | -1,640.00%-87K | ---- | ---5K | ---- | ---- |
Operating profit before the change of operating capital | ---- | 16.06%-79.6M | ---- | -10,779.84%-94.84M | ---- | -96.85%888K | ---- | 157.39%28.17M | ---- | -221.62%-49.08M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 99.66%-25K | ---- | 47.71%-7.29M | ---- | -118.74%-13.93M | ---- | 450.67%74.33M | ---- | 181.60%13.5M |
Accounts receivable (increase)decrease | ---- | 100.94%3.84M | ---- | -230.79%-410.02M | ---- | 210.67%313.49M | ---- | -835.45%-283.27M | ---- | 43.34%-30.28M |
Accounts payable increase (decrease) | ---- | 101.06%3.2M | ---- | -122.14%-300.87M | ---- | 6,569.01%1.36B | ---- | -2,939.19%-21.01M | ---- | -98.19%740K |
Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | 176.72%124.47M | ---- | ---162.25M | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | -925.13%-1.05B | ---- | -117.96%-102.88M | ---- | -156.54%-47.2M |
Cash from business operations | ---- | 92.57%-72.14M | ---- | -233.11%-970.88M | ---- | 256.22%729.4M | ---- | -315.68%-466.91M | ---- | -218.54%-112.33M |
Other taxs | ---- | -28.05%-986K | ---- | 47.55%-770K | ---- | 26.86%-1.47M | ---- | 72.49%-2.01M | ---- | 28.03%-7.3M |
Special items of business | -11.68%-37.82M | ---- | 96.83%-33.86M | ---- | -3,241.66%-1.07B | ---- | 57.40%-31.92M | ---- | -43.04%-74.93M | ---- |
Net cash from operations | -11.68%-37.82M | 92.47%-73.12M | 96.83%-33.86M | -233.48%-971.65M | -3,241.66%-1.07B | 255.24%727.93M | 57.40%-31.92M | -292.00%-468.92M | -43.04%-74.93M | -241.37%-119.62M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 132.00%116K | -85.88%149K | -91.21%50K | -48.79%1.06M | -19.18%569K | -39.77%2.06M | -44.83%704K | 7.14%3.42M | -30.61%1.28M | -3.36%3.19M |
Loan receivable (increase) decrease | ---1.11M | ---- | ---- | 169.21%64.92M | --49.57M | -4,063.03%-93.81M | ---- | 91.50%2.37M | ---- | -83.15%1.24M |
Decrease in deposits (increase) | ---- | ---- | ---- | -196.15%-22.93M | -1,215.97%-51.59M | -271.41%-7.74M | -181.77%-3.92M | 139.58%4.52M | 3,997.44%4.79M | -137.49%-11.41M |
Sale of fixed assets | -89.37%27K | -66.44%345K | 370.37%254K | -91.54%1.03M | -99.52%54K | 6,397.33%12.15M | 8,856.35%11.29M | -92.91%187K | -89.80%126K | -79.31%2.64M |
Purchase of fixed assets | 94.53%-157K | 88.75%-3.58M | 88.16%-2.87M | 67.88%-31.82M | 51.36%-24.21M | 26.26%-99.07M | 30.12%-49.78M | -36.82%-134.34M | -290.96%-71.24M | 6.82%-98.19M |
Sale of subsidiaries | --5M | -70.42%4.88M | ---- | 1,580.55%16.5M | --73.9M | -99.83%982K | ---- | 179.69%582.18M | 152.67%525.66M | --208.16M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --707.13M | 7,315.57%707.13M | ---- | ---9.8M | ---- |
Recovery of cash from investments | 58.63%8.27M | -65.21%7.76M | -29.45%5.21M | 253.20%22.29M | --7.39M | --6.31M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 48.41%-292.8M | -19.16%-268.33M | 18.28%-567.53M | -23,019.10%-225.18M | -225.72%-694.46M | 6.70%-974K | -7,490.17%-213.21M | -60.62%-1.04M | 61.54%-2.81M |
Other items in the investment business | -49.72%12.62M | -85.97%50.67M | -95.32%25.11M | 65.33%361.15M | 448.49%536.28M | 2,640.91%218.44M | 15,273.27%97.77M | 68.42%-8.6M | 102.35%636K | -147.98%-27.23M |
Net cash from investment operations | 110.29%24.76M | -49.75%-232.58M | -165.59%-240.57M | -398.71%-155.31M | -51.88%366.78M | -78.02%52M | 69.23%762.22M | 212.94%236.52M | 172.50%450.41M | 396.27%75.58M |
Net cash before financing | 95.24%-13.05M | 72.87%-305.7M | 60.78%-274.43M | -244.50%-1.13B | -195.83%-699.81M | 435.61%779.93M | 94.50%730.3M | -427.70%-232.39M | 232.57%375.48M | -174.51%-44.04M |
Cash flow from financing activities | ||||||||||
New borrowing | -97.60%2.09M | -94.59%157.81M | -93.79%86.94M | 132.78%2.92B | 217.26%1.4B | 291.23%1.25B | 140.43%441.28M | -73.34%320.26M | -66.50%183.54M | 36.84%1.2B |
Refund | 99.90%-546K | 67.34%-588.53M | 40.57%-532.49M | -25.71%-1.8B | -117.85%-896.05M | -321.10%-1.43B | -154.72%-411.32M | 72.80%-340.38M | 77.11%-161.48M | -35.57%-1.25B |
Interest paid - financing | 94.85%-175K | 93.77%-4.13M | 90.62%-3.4M | -16.47%-66.37M | -48.38%-36.21M | -111.78%-56.98M | -69.65%-24.4M | 41.51%-26.91M | 46.77%-14.38M | 13.49%-46M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | 316.25%259.01M | ---- | 140.79%62.22M | -31.19%17.78M | --25.84M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---55.09M | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | 99.30%-3.19M | -146.57%-447.48M | -202.32%-455.77M | 5,128.19%960.79M | 3,365.23%445.44M | -534.47%-19.11M | -165.91%-13.64M | 105.72%4.4M | 112.88%20.7M | 22.09%-76.84M |
Effect of rate | 122.20%351K | 88.19%-942K | 73.41%-1.58M | -250.49%-7.98M | -235.04%-5.95M | -76.42%5.3M | -57.34%4.4M | 337.54%22.48M | 252.02%10.32M | 48.79%-9.46M |
Net Cash | 97.77%-16.25M | -353.24%-753.17M | -187.07%-730.2M | -121.84%-166.18M | -135.49%-254.37M | 433.70%760.82M | 80.89%716.66M | -88.61%-228M | 928.01%396.18M | -205.91%-120.88M |
Begining period cash | -97.40%20.12M | -18.36%774.24M | -18.36%774.24M | 420.32%948.39M | 420.32%948.39M | -53.00%182.27M | -53.00%182.27M | -25.16%387.79M | -25.16%387.79M | -10.07%518.13M |
Cash at the end | -90.05%4.23M | -97.40%20.12M | -93.83%42.46M | -18.36%774.24M | -23.83%688.08M | 420.32%948.39M | 13.73%903.33M | -53.00%182.27M | 71.37%794.29M | -25.16%387.79M |
Cash balance analysis | ||||||||||
Bank deposits | ---- | 151.71%8.62M | -83.48%10.73M | -93.82%3.43M | --64.95M | 408.16%55.39M | ---- | -77.73%10.9M | 150.55%423.65M | -64.40%48.96M |
Cash and cash equivalent balance | ---- | 151.71%8.62M | -83.48%10.73M | -93.82%3.43M | --64.95M | 408.16%55.39M | ---- | -77.73%10.9M | 150.55%423.65M | -64.40%48.96M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.